Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • Write for us
  • News for You
  • Covid-19
  • Video
  • Podcasts

Search Results for bnt162b2

Phase 1 & 2 Study Reveals CoronaVac COVID-19 Vaccine Candidate Inferior to BNT162B2 & mRNA-1273

A Chinese firm, known as Sinovac, one of the leading COVID-19 vaccine developer contenders, recently revealed results from a peer-reviewed […]

Phase 1 & 2 Study Reveals CoronaVac COVID-19 Vaccine Candidate Inferior to BNT162B2 & mRNA-1273
2 months ago
Share
2

COVID-19 Vaccine Candidate mRNA-1273 (94.5%) beats BNT162b2 (90%) in Interim Analysis: Moderna Prepares to Submit Application for EUA with FDA

Moderna Inc. (Nasdaq: MRNA), the developer of the messenger RNA-based vaccine candidate known as mRNA-1273, reports that the independent NIH […]

COVID-19 Vaccine Candidate mRNA-1273 (94.5%) beats BNT162b2 (90%) in Interim Analysis Moderna Prepares to Submit Application for EUA with FDA
2 months ago
Share
0

European Commission Inks Deal with Pfizer/BioNTech for up to 300m Doses of BNT162b2

The European Commission approved a contract with BioNTech and Pfizer involving the initial purchase of 200 million doses of the […]

European Commission Inks Deal with Pfizer/BioNTech for up to 300m Doses of BNT162b2
3 months ago
Share
0

Reports out of Ireland that Pfizer/BioNTech’s BNT162b2 Very Close to FDA & EMA EUA

Reports out of Ireland suggest that the first COVID-19 vaccine out of the West could be available in Ireland in […]

Reports out of Ireland that PfizerBioNTech’s BNT162b2 Very Close to FDA & EMA EUA
3 months ago
Share
1

Independent Physicians Group in Dayton Serves as Trial Site for BNT162b2 (Pfizer) COVID-19 Vaccine Trial

PriMed Medical Research has already administered the BNT162b2 COVID-19 vaccine candidate to what is reported in the local press, “hundreds” […]

Independent Physicians Group in Dayton Serves as Trial Site for BNT162b2 (Pfizer) COVID-19 Vaccine Trial
4 months ago
Share
0

BioNTech & Pfizer’s BNT162b2 Now Under Rolling Submission Status by EMA: Means COVID-19 Vaccine Could Get Approved Faster

The COVID-19 vaccine candidate known as BNT162b2 may be getting closer to registration (e.g. approval) as the European Medicines Agency […]

BioNTech & Pfizer’s BNT162b2 Now Under Rolling Submission Status by EMA Means COVID-19 Vaccine Could Get Approved Faster
4 months ago
Share
0

University Hospitals Ready Initiation of BNT162b2 Phase 2/3 COVID-19 Vaccine Trial Next Week: Seeking Minority Participation

The Cleveland area will be contributing to the battle against COVID-19 as University Hospitals was selected by Pfizer and BioNTech […]

University Hospitals Ready Initiation of BNT162b2 Phase 23 COVID-19 Vaccine Trial Next Week Seeking Minority Participation
5 months ago
Share
0

mRNA Vaccine Candidate BNT162b2 Shows Promise; Recommended for Large-Scale Trials

A recent study by researchers in the US and Germany of two mRNA-based COVID-19 vaccine candidates found that while they […]

mRNA Vaccine Candidate BNT162b2 Shows Promise; Recommended for Large-Scale Trials
5 months ago
Share
0

Pfizer’s BNT162b2 COVID-19 Vaccine Phase 2/3 Clinical Trial Comes to University Hospitals Cleveland Medical Center

“Project Lightspeed” is coming to University Hospitals Cleveland Medical Center (UH) to conduct the pivotal Phase 2/3 global clinical trial […]

Pfizer’s BNT162b2 COVID-19 Vaccine Phase 23 Clinical Trial Comes to University Hospitals Cleveland Medical Center
5 months ago
Share
0

TGA Provides 2-Year Provisional Approval for Pfizer COVID-19 Vaccine: First Such Approval in Australia

Australia’s drug regulator, the Therapeutic Goods Administration (TGA), granted a provisional approval to Pfizer Australia Pty Ltd for its COVID-19 […]

TGA Provides 2-Year Provisional Approval for Pfizer COVID-19 Vaccine First Such Approval in Australia
1 day ago
Share
0

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • Oxford’s Principal Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
    Oxford’s PRINCIPLE Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.